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ABSTRACT
The purpose of this study was to investigate the effects of phosphatidic acid (PA) supplementation on muscle thickness and strength following an 8-week supervised resistance-training program. Fifteen resistance trained men (22.8±3.5 y; 80.6±8.7 kg; 178.1±5.6 cm; 14.6±8.8% body fat) were randomly assigned to a group that either consumed 750 mg of PA or a placebo (PL). Testing was carried out before (PRE) and after (POST) training/supplementation for muscle thickness and strength. Muscle thickness of the rectus femoris (RF), vastus lateralis (VL), biceps brachii (BB), and triceps brachii (TB) muscles were measured via ultrasonography along with one repetition maximum (1RM) of squat, deadlift, and bench press. Analysis of covariance, using PRE values as the covariate, did not reveal any group differences for measures of muscle thickness in the RF (PA: 3.6±5.2%; PL: 3.2±4.2%, p=0.97), VL (PA: 23.4±18.1%, PL: 12.5±15.4%, p=0.37), BB (PA: 3.7±6.4%, PL: 9.6±12.4%, p=0.86), or TB (PA: 15.1±17.9%, PL: 10.7±19.3%, p=0.79). Likewise, no group differences were observed in changes in squat (PA: 8.4±4.1%, PL: 8.1±4.2%, p=0.79), deadlift (PA: 10.1±10.1%, PL: 8.9±9.5%, p=0.66), or bench press (PA: 5.7±5.5%, PL: 5.1±3.0%, p=0.76) exercises. Collectively, however, all participants experienced significant (p<0.05) improvements in each measure of muscle thickness and strength. Results of this study suggest that PA supplementation, in combination with a 3 days·week -1 resistancetraining program for 8-weeks, did not have a differential effect compared to PL on changes in muscle thickness or 1RM strength.
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INTRODUCTION
Increasing skeletal muscle size and strength has several important implications ranging from disease prevention to increasing sports performance (Egan and Zierath 2013) . Muscle mass accretion is largely governed by the relationship between muscle protein synthesis (MPS) and breakdown, whereby muscle hypertrophy occurs if protein synthesis exceeds breakdown. Moreover, MPS appears to be regulated by the multiprotein phosphorylation cascade known as the mammalian/mechanistic target of rapamycin complex 1 (mTORC1) (Goodman 2014) . Activation of mTORC1 signaling has been shown to be stimulated by several inputs, including growth factors, energy status, amino acids, and mechanical stimuli (Bond 2016) . Several studies have also indicated that mTORC1 signaling is required for mechanically-induced increases in MPS and subsequent hypertrophy (Bodine et al. 2001; Drummond et al. 2009; ).
Resistance exercise is known to be a major regulator for promoting MPS and muscle mass accretion (Gonzalez et al. 2016) . Although the exact mechanism underlying increased mTORC1 activation has not been fully elucidated, resistance exercise has been suggested to promote mTORC1 activation by increasing the abundance of the diacylglycerophospholipid, phosphatidic acid (PA) (Hornberger et al. 2006; Willoughby 2015) .
Along with serving as a major constituent of cell membranes and a precursor for the biosynthesis of other lipids, PA is also suggested to act as an intracellular lipid second messenger, which mediates protein signaling activity (Shad et al. 2015 ). PA appears to be a direct regulator of resistance exercise-induced mTORC1 signaling, acting through distinct mechanisms that converge on the protein kinase, mammalian/mechanistic target D r a f t 4 of rapamycin (mTOR) (Shad et al. 2015) . It has been suggested that PA can bind to the FKBP12-rapamycin binding (FRB) domain of mTOR, and directly activate mTOR kinase activity (Yoon et al. 2011; You et al. 2012) . Therefore, the combination of resistance training and exogenous PA supplementation may up-regulate parallel pathways that converge on mTOR, thereby augmenting MPS and, thus, promote muscle hypertrophy over time (Shad et al. 2015) .
Several studies have shown that administration of PA promotes an increase in mTORC1 activation in vitro and in vivo (Ávila-Flores et al. 2005; Joy et al. 2014; Mobley et al. 2015; Tang et al. 2006; You et al. 2014) . However, few studies have investigated the effects of PA supplementation in humans (Andre et al. 2016; Escalante et al. 2016; Joy et al. 2014 
METHODS AND MATERIALS

Participants
Initially, sixteen resistance-trained men were recruited to participate in this randomized, double-blind, placebo-controlled study. One subject voluntarily withdrew from the study due to time constraints. Fifteen participants (22.8±3.5 y; 80.6±8.7 kg;
178.1±5.6 cm; 14.6±8.8% body fat) completed the study protocol. All participants had a minimum of 1 year of resistance training experience and were currently carrying out strength training sessions at least 2 days per week. All participants were free of any physical limitations that may affect performance, and all participants were free of medications, dietary supplements, and performance enhancing drugs known to increase muscle mass and/or performance, as determined by a health and activity questionnaire.
While enrolled in the study, participants were required to abstain from consuming any other dietary supplements and abstain from training outside of the prescribed protocol (other than activities of daily living). Following an explanation of all procedures, risks, and benefits, each participant provided his informed consent prior to participation in this study. The research protocol was approved by the Hofstra University Institutional
Review Board prior to participant enrollment.
Study protocol
Participants were matched based on baseline measures of body mass and randomly assigned to one of two treatment groups: PA or placebo (PL). Participants D r a f t 6 reported to the Human Performance Laboratory for ultrasonography and strength assessments within 7 days prior to the first dose of supplement and beginning of the resistance-training program (PRE), and within 7 days following the 8-week intervention (POST). Ultrasonography assessments were performed approximately 24 h prior to all strength measures, and each testing session occurred following 72 hours of rest from exercise (other than activities of daily living) to allow proper recovery and ensure that training-induced muscle swelling did not obscure the results (Kristiansen et al. 2014 ).
Supplement protocol
The PA group received 6 capsules per day containing 750 mg of PA. The PL group received 6 capsules per day containing 2.4 grams of psyllium husk fiber. The capsules were similar in appearance (size and color). The dosing strategy was similar to a previous study investigating the effects of PA supplementation (Joy et al. 2014 ). On resistance-training days, participants consumed 3 capsules of their respective supplement 30 minutes prior to resistance training and 3 capsules immediately following resistance training along with 20 g of hydrolyzed collagen protein (Table 1; (Table 2 ). Four sets of each exercise were performed using a load that allowed the participant to complete a 10RM. A 2-min rest interval was allowed between sets and exercises. Exercises and repetition schemes remained the same for all 8 weeks. All participants were required to perform 10 repetitions with their prescribed weight. In the event that a participant reached muscular failure, a researcher assisted with the completion of the exercise.
Training loads for a give exercise were increased if the participant could complete all 4 sets of 10 repetitions with proper technique prior to muscular failure. ***INSERT TABLE 2 HERE***
Muscle thickness assessment
Noninvasive skeletal muscle ultrasound images were collected from the dominant thigh and arm locations of all participants using B-mode ultrasound imaging with a 12-MHz linear probe (VSCAN, General Electric Medical Systems, Milwaukee, WI, USA).
Each participant laid supine on the examination table for a minimum of 15 min to allow fluid shifts to occur before images were collected (Berg et al. 1993 ). Prior to image collection, all anatomical locations of interest were identified using standardized landmarks for the rectus femoris (RF), vastus lateralis (VL), triceps brachii (TB), and biceps brachii (BB) muscles (Mangine et al. 2015) . .50 cm) were determined in 10 healthy college-aged males using methodology described above.
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Strength assessment
During each testing session, participants performed a one-repetition maximum (1RM) strength test for the barbell back squat, deadlift, and bench press exercises using a standard protocol (Hoffman 2006) . Prior to maximal strength testing, participants performed a standardized warm-up consisting of 10 body weight squats, 10 body weight walking lunges, 10 dynamic walking hamstring stretches, 10 dynamic walking quadriceps stretches, and 10 body weight pushups. For each exercise, participants performed two warm-up sets using a resistance of approximately 40-60% of estimated 1RM for 6-10
repetitions and 60-80% of estimated 1RM for 3-5 repetitions, respectively. The weight was then increased conservatively, and the participant attempted to lift the weight for one repetition. A 3-5 minute rest period was provided between each attempt. This procedure continued until the participant failed to complete the lift. The 1RM was recorded as the maximum weight that the participant was able to lift for one repetition. All testing was completed under the supervision of a CSCS.
A successful lift in the squat required the participant to descend to a thigh parallel position defined by the trochanter head of the femur reaching the same horizontal plane as the superior border of the patella. An investigator located lateral to the participant provided an "Up!" signal indicating when proper range of motion had been achieved.
Deadlifts were performed with a conventional shoulder width stance, and a successful lift required the participant to achieve an erect body posture with the knees straightened and shoulders retracted upon completion of the movement. Bench press was performed with a conventional shoulder width grip, and a successful lift required the participant to lower the bar until lightly touching the chest (i.e., subjects were not permitted to bounce the bar D r a f t 10 off of the chest) prior to lifting the bar back to a straight-arm position with the hips and feet remaining in contact with the bench and floor, respectively, throughout the lift (Hoffman 2006 ).
Dietary analysis
Participants were advised to maintain their normal diet and to avoid taking any supplements other than those provided in the study. To assess the potential confounding impact of dietary intake, self-reported food records were collected during the first (week 1) and final week (week 8) of the study. Participants were instructed on how to properly complete a three-day dietary recall log to include all food items and their respective portion sizes that were consumed. Dietary analysis software (MyFitnessPal
®
) was used to analyze dietary recalls to assess potential differences in total energy and macronutrient intakes between groups.
Statistical analysis
To identify differences between the experimental conditions on changes in muscle size and strength, an analysis of covariance (ANCOVA) was performed on all measures collected at POST. Associated values collected at PRE were used as the covariate to eliminate the possible influence of initial score variances on the outcomes. Following any significant F-ratio, a paired-samples t-test was used to determine if significant difference existed between measures collected prior to and immediately following 8 weeks of training. All between group differences were further analyzed using effect sizes (η 2 : partial eta squared). Interpretations of effect size were evaluated (Green et al. 2000) at the following levels: small effect (0.01-0.059), medium effect (0.06-0.139) and large effect (>0.14). A criterion alpha level of p<0.05 was used to determine statistical D r a f t significance. All data are reported as mean ± standard deviation. Statistical Software (V.
21.0, SPSS Inc., Chicago, IL) was used for all analyses.
RESULTS
Participant compliance, reported side effects & dietary analysis
Resistance training and supplement compliance was high (both >98%) with no differences between groups. PA and PL supplements were well tolerated and no adverse side effects were reported. No significant differences (p>0.05) were noted for caloric intake (2260.1±736.3 kcal vs. 2111.1±740.8 kcal), carbohydrate intake (234.3±69.1 g vs.
230
.4±112.2 g), fat intake (90.3±42.1 g vs. 82.5±33.0 g), protein intake (121.7±40.0 g vs.
121
.2±31.4 g), or relative protein intake (1.5±0.5 g vs. 1.6±0.6 g) during week 1 between PA and PL, respectively. Additionally, no significant differences (p>0.05) were noted when comparing the participants' nutritional intake during week 1 and week 8 of the study.
Muscle thickness and strength
When using PRE values as the covariate, no group differences were observed for any measure of muscle thickness or strength following 8-weeks of resistance training.
Collectively, significant improvements occurred in both groups for all measures of muscle thickness (p<0.05) and strength (p<0.001). The changes in muscle thickness and strength following 8 weeks of resistance training are presented in Table 3 . press exercises.
The literature to date indicates that direct binding of PA to mTOR activates downstream mTORC1 signaling (Hornberger et al. 2006; Willoughby 2015) . Thus, it is tenable that increasing the presence of PA within skeletal muscle through oral supplementation, in conjunction with a mechanical stimulus, would augment mTORC1 signaling and promote greater increases in muscle hypertrophy. However, to date, no study has examined the effectiveness of PA supplementation in combination with resistance exercise on increasing intramuscular concentrations of PA or augmenting mTORC1 activity in human skeletal muscle. Nevertheless, previous studies have investigated the efficacy of PA supplementation in combination with resistance training on changes in body composition, muscle mass, and strength in trained men (Andre et al. 2016; Escalante et al. 2016; Hoffman et al. 2012; Joy et al. 2014) . Hoffman et al. (2012) and Andre et al. (2016) greater increases in lean body mass, RF cross sectional area, and 1RM leg press strength as a result of PA supplementation, while no differences were noted for bench press strength. Escalante et al. (2016) demonstrated greater increases in lean body mass, 1RM
leg press strength, and 1RM bench press strength, while no differences were noted for thigh muscle mass, vertical jump, agility, or peak power output. However, the supplement administered in Escalante et al. (2016) included a proprietary blend of Lleucine, HMB, and vitamin D3 which makes it difficult to discern if the results were attributable to PA.
In the current investigation, no significant differences in muscle architecture or strength measures were found following PA supplementation compared to PL. Similar to Hoffman et al. (2012) , we found no statistical interactions between groups for VL thickness, squat strength, and bench press strength. It is unclear why discrepancies exist in study outcomes following PA supplementation in conjunction with an 8-week resistance-training program. With the exception of Andre et al. (2016) , previous investigations provided resistance-trained men with 750 mg·day -1 prior to and immediately following resistance training along with a collagen protein source in resistance-trained men. Andre et al. (2016) activation, dissociation between anabolic signaling and MPS may exist, whereby mTORC1 activation is not consistently associated with MPS rates (Greenhaff et al. 2008; Mitchell et al. 2015) . Therefore, upregulation of anabolic signaling in vitro may provide little, if any, explanation towards the dynamic process of muscle hypertrophy in humans (Damas et al. 2015 
